Abstract: The present invention provides compositions and methods for immunotherapy, which include shelf-stable pharmaceutical compositions for inducing antigen-specific T cells. Such compositions are employed as components of an artificial antigen presenting cell (aAPC), to provide a patient with complexes for presentation of an antigen (e.g., a tumor antigen) and/or a T cell co-stimulatory molecule.
Type:
Application
Filed:
June 23, 2014
Publication date:
May 12, 2016
Applicant:
Nexlmmune, Inc.
Inventors:
Bruce McCreedy, Timothy David Jones, Francis Joseph Carr